Anti-SARS-CoV-2 Spike RBD Neutralizing Antibody, Chimeric mAb, Human IgA1 (AM122)
Anti-SARS-CoV-2 Spike RBD Neutralizing Antibody, Human IgA1 (AM122) is a chimeric monoclonal antibody recombinantly expressed from HEK293 cells, which combines the variable region of a mouse monoclonal antibody with human IgA1 constant domain. The mouse monoclonal antibody was obtained from a mouse immunized with recombinant SARS-CoV-2 Spike S1 protein.
Product #: SPD-M58P1-100ug-202 Unit size: 100ug*1 Supplier: ACROBiosystems Available in the following countries:Got any questions?
Get in touch with one of our specialists
Cristina Battagli
Product Specialist: Diagnostics, Metabolomics, Imaging & Cell Biology